ES542927A0 - Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn - Google Patents

Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn

Info

Publication number
ES542927A0
ES542927A0 ES542927A ES542927A ES542927A0 ES 542927 A0 ES542927 A0 ES 542927A0 ES 542927 A ES542927 A ES 542927A ES 542927 A ES542927 A ES 542927A ES 542927 A0 ES542927 A0 ES 542927A0
Authority
ES
Spain
Prior art keywords
lantanid
nmr
contrast
complex
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES542927A
Other languages
English (en)
Other versions
ES8603757A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of ES542927A0 publication Critical patent/ES542927A0/es
Publication of ES8603757A1 publication Critical patent/ES8603757A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Signal Processing (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Immunology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
ES542927A 1983-08-12 1985-05-08 Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn Expired ES8603757A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313281A FR2550449B1 (fr) 1983-08-12 1983-08-12 Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire

Publications (2)

Publication Number Publication Date
ES542927A0 true ES542927A0 (es) 1986-01-01
ES8603757A1 ES8603757A1 (es) 1986-01-01

Family

ID=9291604

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535097A Expired ES8700058A1 (es) 1983-08-12 1984-08-10 Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmn
ES542928A Expired ES8603758A1 (es) 1983-08-12 1985-05-08 Procedimiento para la obtencion de un complejo lantanido pa-ramagnetico de efecto modificador del contraste de una ima- gen medica por rmn.
ES542927A Expired ES8603757A1 (es) 1983-08-12 1985-05-08 Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES535097A Expired ES8700058A1 (es) 1983-08-12 1984-08-10 Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmn
ES542928A Expired ES8603758A1 (es) 1983-08-12 1985-05-08 Procedimiento para la obtencion de un complejo lantanido pa-ramagnetico de efecto modificador del contraste de una ima- gen medica por rmn.

Country Status (5)

Country Link
US (1) US4804529A (es)
EP (1) EP0133603A1 (es)
JP (1) JPS60100526A (es)
ES (3) ES8700058A1 (es)
FR (1) FR2550449B1 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330801A1 (en) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
ZA852979B (en) * 1984-04-27 1985-11-27 Vestar Research Inc Contrast agents for nmr imaging
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5141739A (en) * 1986-07-03 1992-08-25 Advanced Magnetics, Inc. Delivery of x-ray contrast agents using receptor mediated endocytosis
US5219553A (en) * 1986-08-04 1993-06-15 Salutar, Inc. Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI
US5039512A (en) * 1986-08-04 1991-08-13 Salutar, Inc. NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
JPS6456043A (en) * 1987-08-27 1989-03-02 Nippon Oil Co Ltd Preparation of phantom for nmr diagnosis
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
GB8813425D0 (en) * 1988-06-07 1988-07-13 Hall L D Magnetic resonance imaging
JPH04501560A (ja) * 1988-08-24 1992-03-19 ザ ユニバーシティ オブ コネチカット 磁気共鳴断層撮影の能力向上に役立つ担体システム並びに方法
DE3834704A1 (de) * 1988-10-07 1990-06-07 Schering Ag Fluorsubstituierte benzolderivate
US5019370A (en) * 1989-07-10 1991-05-28 University Of Kentucky Research Foundation Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
FR2654344B1 (fr) * 1989-11-16 1994-09-23 Cis Bio Int Complexe paramagnetique de gadolinium, son procede de preparation et son utilisation pour le diagnostic par irm.
US5516503A (en) * 1989-11-16 1996-05-14 Guerbet S.A. Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
ES2091251T3 (es) * 1989-11-27 1996-11-01 Concat Ltd Perfeccionamiento de la imagen en la mri del hueso y del tejido emparentado utilizando complejos de cationes paramagneticos y ligandos polifosfonato.
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
DE4008179A1 (de) * 1990-03-12 1991-09-19 Schering Ag Fluorbenzolsulfonamide
US5154914A (en) * 1990-03-12 1992-10-13 Research Corporation Technologies, Inc. Methods of diagnostic image analysis using lipophilic contrast agents
US5242681A (en) * 1990-03-12 1993-09-07 Research Corporation Technologies, Inc. Lipophilic contrast agents for diagnostic image analysis
GB9006671D0 (en) * 1990-03-24 1990-05-23 Univ Manchester Diagnostic method and compositions
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5169944A (en) * 1991-04-12 1992-12-08 Board Of Regents Of The University Of Washington Methods and compositions for the enteral administration of hepatobiliary MRI contrast agents
JPH06507904A (ja) * 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 磁気共鳴画像形成用の油脂可溶化合物
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
DE69207589T2 (de) * 1992-06-01 1996-05-23 Basf Ag Anwendung von Dispersionen von magneto-ionischen Partikeln in MRI-Kontrast-Mitteln
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
CA2147151A1 (en) * 1992-10-14 1994-04-28 Robert A. Snow Therapeutic and diagnostic imaging compositions and methods
DE69312951T2 (de) * 1992-10-14 1997-12-11 Nycomed Imaging As Chelatpolymere
US5525324A (en) * 1993-08-06 1996-06-11 Block; Ronald E. Organic silicon contrast agents and methods of use
US5409689A (en) * 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US6122540A (en) * 1994-06-08 2000-09-19 The Regents Of The University Of California Noninvasive measurement of renal hemodynamic functions using magnetic resonance imaging
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
TW319763B (es) 1995-02-01 1997-11-11 Epix Medical Inc
EP0955044B1 (en) 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
EP1031354A3 (en) 1999-01-19 2003-02-05 Rohm And Haas Company Polymeric MRI Contrast agents
FR2801299B1 (fr) * 1999-11-23 2002-06-07 Rhodia Terres Rares Dispersion colloidale aqueuse a base d'au moins un compose d'un lanthanide et d'un complexant, procede de preparation et utilisation
FR2867473B1 (fr) * 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
KR102263060B1 (ko) * 2014-09-02 2021-06-09 삼성전자주식회사 금이온을 포함하는 이노시톨 폴리포스페이트 복합체, 및 그의 용도 및 제조방법
JP2024503441A (ja) * 2021-01-20 2024-01-25 ビーム セラピューティクス インク． イオン化可能な脂質を含むナノ材料

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322M (fr) * 1961-04-15 1964-02-10 Richter Gedeon Vegyeszet Complexes solubles dans l'eau des métaux du groupe du lanthane utilisables comme médicaments.
US3789060A (en) * 1971-11-03 1974-01-29 Wisconsin Alumni Res Found Fluorinated camphor derivatives and europium and praseodymium chelates thereof
US4156683A (en) * 1973-03-26 1979-05-29 Schering Corporation Complexes of macrocyclic compounds
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik

Also Published As

Publication number Publication date
JPS60100526A (ja) 1985-06-04
FR2550449A1 (fr) 1985-02-15
ES535097A0 (es) 1986-10-16
US4804529A (en) 1989-02-14
ES542928A0 (es) 1986-01-01
ES8603757A1 (es) 1986-01-01
FR2550449B1 (fr) 1986-01-31
ES8603758A1 (es) 1986-01-01
EP0133603A1 (fr) 1985-02-27
ES8700058A1 (es) 1986-10-16

Similar Documents

Publication Publication Date Title
ES542927A0 (es) Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn
FR2602145B3 (fr) Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn
ES529270A0 (es) Sistema ultrasonido de exploracion del tejido de un paciente, para la formacion de una imagen para diagnostico.
BR8405424A (pt) Coletor de luz para instrumentos para exame oftalmologico
IT7868243A0 (it) Procedimento per la regolazione del la marcia sincronizzata di una dentatrice e dispositivo per la sua attuazione
IT1192616B (it) Apparecchio formatore di immagini in particolare per diagnosi delle funzionalita' del cervello
MX5958E (es) Procedimiento microbiologico para la preparacion del antibiotico a/16686
AR227146A1 (es) Un soporte contrabalanceado para una silla para pacientes o una fuente de radiacion
MX6053E (es) Procedimiento microbiologico para la preparacion de derivados del sesquiterpeno
AR192786A1 (es) Procedimiento para la preparacion de nuevos n-amina-terciaria-metil-4'dibenzo(b,e)oxepina-11-espiro-2'dioxolanos-1',3'
ES529423A0 (es) Un procedimiento para la preparacion de un genero esterilizable de coste reducido desechable despues del uso.
IT1133122B (it) Ratiera rotante con innesto a cuneo per il movimento del quadro dei licci
AR218600A1 (es) Procedimiento para la preparacion de derivados 2(3),7(8)-disustituida 10(n'-ciclamidoalquil-n-piperazinil)dibenzo (b,f)tiepina
ES499834A0 (es) Procedimiento para la obtencion de nuevos derivados del aci-do lignosulfonicos
ES494546A0 (es) Un procedimiento para la preparacion de derivados del pirrol
NO151487C (no) Vannlatingsinnretning for sengeliggende, kvinnelige pasienter
ES493068A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
ES490419A0 (es) Telar circular para la produccion de tejidos tubulares
ES535582A0 (es) Procedimiento para la obtencion de derivados del 2-aminometil-2-penem
BE856446A (fr) Procede de preparation d'amoxycilline sodique
ES494064A0 (es) Procedimiento para la obtencion de colorantes estirilicos
IT1237546B (it) Procedimento per la preparazione del clotrimazolo
SE7803781L (sv) Apparat for medicinsk diagnostik
ES489876A0 (es) Un procedimiento para la produccion de una imagen fotografi-ca
ES495153A0 (es) Procedimiento para la obtencion de derivados del decahidro- quinolinol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519